Your Ad Here
PatientsVille.com> Hemofil Report List> Hemofil Side Effects
If You had Hemofil side effect, You are not alone. Other patients reported side effects.
Do You Have Hemofil Side Effects? Enter Your Symptoms:
Use to quickly submit your side effect

Report Detailed Information

Detailed Reporting will help others get complete information and find alternative treatments to avoid or reduce side effects associated with it.

Ask Hemofil Community

Ask patient community about Hemofil related health issues.

View FDA Reports

Hemofil adverse events reported to FDA.

Have You Experienced unusual Hemofil symptoms? PatientsVille.com collects and analyzes Hemofil side effect and adverse reports submitted by Hemofil users, such as .

Summary

FDA Adverse Reports: 16. View All

Hemofil FDA safety alerts: No

Reported deaths: 1

Reported hospitalizations: 11

More About Hemofil

Post Your Unusual Symptoms:

Most Reported
Recent Drug Reports

More Hemofil Side Effect Reports

Questions

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

blog comments powered by Disqus

Often additional risks of using a medication, such as Hemofil, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Hemofil users, Learn more about unwanted side effects & find ways to reduce them. Browse Hemofil Adverse Reports reported to FDA and participate in Hemofil discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Hemofil. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines. Browse More Drug Reports Here: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Search By Drug Names, Symptoms or a Health Condition

Loading

Hemofil Adverse Effect Reports (FDA)

For a quick way to Report Unusual Symptoms, Enter here:

5003250-9 | Hepatitis B, Hepatitis C, Hiv Infection
on Apr 18, 2006 Male patient from GERMANY , child 9 years of age, was diagnosed with factor viii deficiency and was treated with Hemofil (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?), hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?). Hemofil dosage: . During the same period patient was treated with FACTOR VIII (ANTIHAEMOPHILIC FACTOR) (FACTOR VIII (ANTIHAEMOPHILIC FAC (View Factor Viii (antihaemophilic Factor) (factor Viii (antihaemophilic Fac Review and Factor Viii (antihaemophilic Factor) (factor Viii (antihaemophilic Fac Label ).

4989860-3 | Hepatitis C, Hiv Test Positive
Patient was taking Hemofil (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?), hiv test positive (What is hiv test positive?) on Apr 13, 2006 from GERMANY Additional patient health information: Male patient , 55 years of age, was diagnosed with factor viii deficiency, von willebrand's disease and. Hemofil dosage: . During the same period patient was treated with FACTOR VIII (ANTIHAEMOPHILIC FACTOR) (FACTOR VIII (ANTIHAEMOPHILIC FAC (View Factor Viii (antihaemophilic Factor) (factor Viii (antihaemophilic Fac Review and Factor Viii (antihaemophilic Factor) (factor Viii (antihaemophilic Fac Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), PLASMA CRYOPRECIPITATE (View Plasma Cryoprecipitate Review and Plasma Cryoprecipitate Label ).

4809365-X | Adverse Event, Hepatitis C
Adverse event was reported on Oct 06, 2005 by a Male patient taking Hemofil (View Usage) (Dosage: ) was diagnosed with haemophilia and. Location: GERMANY , 24 years of age, After Hemofil was administered, patient had the following side effects: adverse event, hepatitis c (What is hepatitis c?). During the same period patient was treated with PROPLEX T (View Proplex T Review and Proplex T Label ).

4809358-2 | Adverse Event, Hepatitis B, Hepatitis C
on Oct 06, 2005 Male patient from GERMANY , 14 years of age, was diagnosed with haemophilia and was treated with Hemofil (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, hepatitis b (What is hepatitis b?), hepatitis c (What is hepatitis c?). Hemofil dosage: . During the same period patient was treated with PROPLEX T (View Proplex T Review and Proplex T Label ).


4763352-9 | Hepatitis C
on Aug 23, 2005 Male patient from GERMANY , 41 years of age, was diagnosed with haemophilia and was treated with Hemofil (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?). Hemofil dosage: . During the same period patient was treated with PROPLEX T (View Proplex T Review and Proplex T Label ).

4723708-7 | Hepatitis C Virus
Patient was taking Hemofil (View Usage). After Hemofil was administered, patient had the following side effects: hepatitis c virus on Mar 08, 2005 from GERMANY Additional patient health information: Male patient , 41 years of age, was diagnosed with haemophilia and. Hemofil dosage: . During the same period patient was treated with PROPLEX T (View Proplex T Review and Proplex T Label ).

4714705-6 | Hepatitis
Adverse event was reported on Sep 17, 2052 by a Male patient taking Hemofil (View Usage) (Dosage: ) was diagnosed with haemophilia and. Location: GERMANY , 13 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?).

4677335-0 | Compartment Syndrome, Haemorrhage
on May 12, 2005 Male patient from , child 8 years of age, was diagnosed with haemophilia and was treated with Hemofil (View Usage). Patient had the following side effects: compartment syndrome, haemorrhage. Hemofil dosage: . Patient was hospitalized.

4597138-5 | Hepatitis C Virus
on Feb 15, 2005 Male patient from , 49 years of age, was diagnosed with factor viii deficiency and was treated with Hemofil (View Usage). After Hemofil was administered, patient had the following side effects: hepatitis c virus. Hemofil dosage: Intravenous. During the same period patient was treated with CUTTER FACTOR VIII (Intravenous) (View Cutter Factor Viii Review and Cutter Factor Viii Label ), ALPHA FACTOR VIII (View Alpha Factor Viii Review and Alpha Factor Viii Label ), ANTIHEMOPHILIC FACTOR (HUMAN) (View Antihemophilic Factor (human) Review and Antihemophilic Factor (human) Label ), PLASMA (View Plasma Review and Plasma Label ), CRYOPRECIPITATED AHF (View Cryoprecipitated Ahf Review and Cryoprecipitated Ahf Label ).

4593900-3 | Hepatitis C Virus
Patient was taking Hemofil (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c virus on Feb 01, 2005 from Additional patient health information: Male patient , 52 years of age, was diagnosed with factor viii deficiency and. Hemofil dosage: Unk. During the same period patient was treated with KOATE (Unk) (View Koate Review and Koate Label ), WHOLE BLOOD (Unk) (View Whole Blood Review and Whole Blood Label ), PLASMA (Unk) (View Plasma Review and Plasma Label ).

4590604-8 | Hepatitis C Virus
Adverse event was reported on Jan 31, 2005 by a Male patient taking Hemofil (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: , 57 years of age, Patient had the following side effects: hepatitis c virus. During the same period patient was treated with BAYER/ CUTTER (FACTOR VIII) (UNCODED) (View Bayer/ Cutter (factor Viii) (uncoded) Review and Bayer/ Cutter (factor Viii) (uncoded) Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), PLASMA (View Plasma Review and Plasma Label ), KRIOPRECIPITAT (FACTOR VIII (ANTIHAEMOPHILIC FACTOR)) (View Krioprecipitat (factor Viii (antihaemophilic Factor)) Review and Krioprecipitat (factor Viii (antihaemophilic Factor)) Label ).

4590522-5 | Hepatitis C Virus
on Feb 01, 2005 Male patient from , 58 years of age, was diagnosed with factor viii deficiency and was treated with Hemofil (View Usage). After Hemofil was administered, patient had the following side effects: hepatitis c virus. Hemofil dosage: . During the same period patient was treated with CUTTER (FACTOR VIII) (UNCODED) (View Cutter (factor Viii) (uncoded) Review and Cutter (factor Viii) (uncoded) Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), PLASMA (View Plasma Review and Plasma Label ), KRIOPRECIPITAT (FACTOR VIII (ANTIHAEMOPHILIC FACTOR)) (View Krioprecipitat (factor Viii (antihaemophilic Factor)) Review and Krioprecipitat (factor Viii (antihaemophilic Factor)) Label ).

4585758-3 | Hepatitis C Virus
on Jan 26, 2005 Male patient from , 27 years of age, was diagnosed with factor viii deficiency and was treated with Hemofil (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c virus. Hemofil dosage: . During the same period patient was treated with KOATE (View Koate Review and Koate Label ), CRYOPRECIPITATED AHF (View Cryoprecipitated Ahf Review and Cryoprecipitated Ahf Label ).

4579780-0 | Hepatitis C Virus
Patient was taking Hemofil (View Usage). Patient had the following side effects: hepatitis c virus on Jan 24, 2005 from Additional patient health information: Male patient , 17 years of age, was diagnosed with factor viii deficiency and. Hemofil dosage: Intravenous. During the same period patient was treated with KOATE (View Koate Review and Koate Label ).

4579776-9 | Hepatitis C Virus
Adverse event was reported on Jan 24, 2005 by a Female patient taking Hemofil (View Usage) (Dosage: Intravenous) was diagnosed with factor viii deficiency and. Location: , 22 years of age, After Hemofil was administered, patient had the following side effects: hepatitis c virus. During the same period patient was treated with KOATE (View Koate Review and Koate Label ), CRYOPRECIPITATED AHF (View Cryoprecipitated Ahf Review and Cryoprecipitated Ahf Label ).

4477443-3 | Hiv Infection
on Sep 20, 2004 Male patient from , 32 years of age, was diagnosed with factor viii deficiency and was treated with Hemofil (View Usage). Patient experienced the following unwanted or unexpected effects: hiv infection (What is hiv infection?). Hemofil dosage: . During the same period patient was treated with KRYOBULIN A (HUMAN COAGULATION FACTOR VIII (A)) (View Kryobulin A (human Coagulation Factor Viii (a)) Review and Kryobulin A (human Coagulation Factor Viii (a)) Label ), KOATE (View Koate Review and Koate Label ), FACTORATE (FACTOR VIII (ANTIHAEMOPHILIC FACTOR)) (View Factorate (factor Viii (antihaemophilic Factor)) Review and Factorate (factor Viii (antihaemophilic Factor)) Label ), PROFILATE (View Profilate Review and Profilate Label ), HUMANATE (UNCODED) (View Humanate (uncoded) Review and Humanate (uncoded) Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), KRIOPRECIPITAT (FACTOR VII1(ANTIHAEMOPHILIC FACTOR)) (View Krioprecipitat (factor Vii1(antihaemophilic Factor)) Review and Krioprecipitat (factor Vii1(antihaemophilic Factor)) Label ).


Share Your Experience, Join the Discussion:

Go to the top of the page

Hemofil Questions, Answers, Feedback and Comments

No comments have been provided.

To find out about documented side effects or safety concerns read either the drug label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. All medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety alerts, adverse reports. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Be aware of the following potential Hemofil risks to be aware of: 1. Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
2. Any potential Hemofil quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
3. Potential Hemofil use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
4. When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

Go to the top of the page
Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

HEPATITIS C, view Drugs and Side Effects associated with HEPATITIS C, ,HEPATITIS C HEMOFIL,HEPATITIS C KOATE,HEPATITIS C AUGMENTIN,HEPATITIS C CLOZARIL,HEPATITIS C ...

ADVERSE EVENT, view Drugs and Side Effects associated with ADVERSE EVENT, ,ADVERSE EVENT VIOXX,ADVERSE EVENT KOATE,ADVERSE EVENT FOSAMAX,ADVERSE EVENT HEMOFIL,ADVERSE ...

Report a Drug Side Effect. ... This anonymous Drug Side Effect Survey has 13 questions and takes less than 2 minutes to complete.

HEPATITIS C, view Drugs and Side Effects associated with HEPATITIS C, ,HEPATITIS C HEMOFIL,HEPATITIS C KOATE,HEPATITIS C AUGMENTIN,HEPATITIS C CLOZARIL,HEPATITIS C ...

... and haemorrhage, Monarc and injection site urticaria, Monarc and soft tissue haemorrhage. Monarc dosage: Unk. During the same period patient was treated with HEMOFIL M, ...

... After Norco was administered, patient had the following side effects: malaise. During the same period patient was treated with HEMOFIL M (View Hemofil M Review and Hemofil ...

HEPATITIS, view Drugs and Side Effects associated with HEPATITIS, ,HEPATITIS HEMOFIL,HEPATITIS KETEK,HEPATITIS CYMBALTA,HEPATITIS AUGMENTIN,HEPATITIS KOATE,HEPATITIS ...

HEPATITIS, view Drugs and Side Effects associated with HEPATITIS, ,HEPATITIS HEMOFIL,HEPATITIS KETEK,HEPATITIS CYMBALTA,HEPATITIS AUGMENTIN,HEPATITIS KOATE,HEPATITIS ...

HEPATITIS, view Drugs and Side Effects associated with HEPATITIS, ,HEPATITIS HEMOFIL,HEPATITIS KETEK,HEPATITIS CYMBALTA,HEPATITIS AUGMENTIN,HEPATITIS KOATE,HEPATITIS ...

hemofil Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: humira Episodes: 1: Diagnosed with major depression.Side ...

> Medical Devices

> Side Effects Wiki

Follow Us on Twitter

Hemofil Reactions
Adverse Event
Compartment Syndrome
Haemorrhage
HepatitisWhat is Hepatitis?
Hepatitis BWhat is Hepatitis b?
Hepatitis CWhat is Hepatitis c?
Hepatitis C Virus
Hiv Infection
Hiv Test Positive
Hemofil Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Hemofil adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!